PMID- 22260869 OWN - NLM STAT- MEDLINE DCOM- 20120718 LR - 20121115 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 206 DP - 2012 Mar 29 TI - Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun. PG - 25-38 LID - 10.1016/j.neuroscience.2012.01.001 [doi] AB - Arsenite treatment of human SH-SY5Y neuroblastoma cells leads to an upregulation of caspase-3/7 activity and to the fragmentation of chromatin that is accompanied by elevated p53 and c-Jun levels. Expression of a truncated mutant of p53, p53DD, which interfered with the oligomerization of p53, suppressed the arsenite-induced upregulation of caspase-3/7 activity and the fragmentation of chromatin, indicating that p53 is required for arsenite-induced cell death. These data were corroborated by knockdown experiments of p53 following expression of a p53-specific short hairpin RNA. Likewise, expression of either p53DD or knockdown of p53 prevented caspase-3/7 activation and chromatin fragmentation induced by nutlin-3, a compound that prevents the interaction between p53 and the E3 ubiquitin ligase MDM2. Transcriptional upregulation of a chromatin-embedded p53-responsive reporter gene in either arsenite or nutlin-3 stimulated neuroblastoma cells revealed that the transcriptional activity of p53 was increased under these conditions. Expression of a c-Jun-specific short hairpin RNA failed to impair arsenite-induced caspase-3/7 activation and fragmentation of chromatin. Likewise, inhibition of c-Jun target gene expression by expression of a dominant-negative mutant of c-Jun did not interfere with arsenite-induced caspase-3/7 activation and chromatin fragmentation. However, this approach successfully reduced caspase-3/7 activity induced as a result of forced expression of a constitutively active mutant of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase (MEKK)-1. Together, these data show that the upregulation of p53 is causally linked with arsenite-induced cell death in neuroblastoma cells, whereas the upregulation of c-Jun is not part of this apoptotic signaling cascade. CI - Copyright (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved. FAU - Keim, A AU - Keim A AD - Department of Medical Biochemistry and Molecular Biology, University of Saarland Medical Center, D-66421 Homburg, Germany. FAU - Rossler, O G AU - Rossler OG FAU - Rothhaar, T L AU - Rothhaar TL FAU - Thiel, G AU - Thiel G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120108 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Antineoplastic Agents) RN - 0 (Arsenites) RN - 0 (Proto-Oncogene Proteins c-jun) RN - 0 (TP53 protein, human) RN - 0 (Tumor Suppressor Protein p53) RN - N5509X556J (arsenite) SB - IM MH - Antineoplastic Agents/*pharmacology MH - Apoptosis/*drug effects MH - Arsenites/*pharmacology MH - Blotting, Western MH - Cell Line, Tumor MH - Humans MH - In Situ Nick-End Labeling MH - Neuroblastoma/*metabolism MH - Proto-Oncogene Proteins c-jun/metabolism MH - Signal Transduction/*drug effects/physiology MH - Tumor Suppressor Protein p53/*metabolism EDAT- 2012/01/21 06:00 MHDA- 2012/07/19 06:00 CRDT- 2012/01/21 06:00 PHST- 2011/11/03 00:00 [received] PHST- 2011/12/21 00:00 [revised] PHST- 2012/01/02 00:00 [accepted] PHST- 2012/01/21 06:00 [entrez] PHST- 2012/01/21 06:00 [pubmed] PHST- 2012/07/19 06:00 [medline] AID - S0306-4522(12)00003-6 [pii] AID - 10.1016/j.neuroscience.2012.01.001 [doi] PST - ppublish SO - Neuroscience. 2012 Mar 29;206:25-38. doi: 10.1016/j.neuroscience.2012.01.001. Epub 2012 Jan 8.